表紙
市場調査レポート

神経修復・再生の世界市場の予測 〜2020年:手術・処置 (神経縫合術・神経移植術・幹細胞治療・神経刺激術)・製品別

Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), & by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Devices) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 281743
出版日 ページ情報 英文 144 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
神経修復・再生の世界市場の予測 〜2020年:手術・処置 (神経縫合術・神経移植術・幹細胞治療・神経刺激術)・製品別 Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), & by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Devices) - Global Forecast to 2020
出版日: 2015年08月07日 ページ情報: 英文 144 Pages
概要

世界の神経修復・再生市場の規模は2015年から2020年にかけて11.83%のCAGRで推移し、2015年の59億4569万米ドルから2020年には103億9879万米ドルの規模に成長すると予測されています。末梢神経の損傷や神経疾患件数の急激な増加、神経修復技術の進歩、有利な償還政策などが同市場の主な成長推進要因となっています。

当レポートでは、世界の神経修復・再生市場について調査し、神経の修復・再生ための手術・処置の種類と概要、用いられる装置および材料の種類と概要、市場成長への各種影響因子の分析、手術&処置・装置&材料・地域別の市場分析および市場成長予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界市場の概要
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 製品別
    • 用途別
  • 市場力学
    • 推進要因
    • 抑制要因
    • 市場機会
    • 課題

第6章 製品別市場

  • イントロダクション
  • 神経刺激・神経調整装置
    • 内部神経刺激装置
      • 脊髄刺激
      • 深部脳刺激
      • 迷走神経刺激
      • 仙骨神経刺激
      • 胃電気刺激
    • 外部神経刺激装置
      • 経皮電気神経刺激
      • 経頭蓋磁気刺激
  • 生体材料
    • 神経管
    • 神経プロテクター
    • 神経ラップ
    • 神経コネクター

第7章 手術・用途別市場

  • イントロダクション
  • 神経刺激・神経調節手術
    • 内部
    • 外部
  • 直接神経修復・神経縫合術
    • 神経上膜修復
    • 神経周囲修復
    • グループ神経束修復
  • 神経移植術
    • 自家移植
    • 同種移植
    • 異種移植
  • 幹細胞治療

第8章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第9章 競合環境

  • イントロダクション
  • 戦略的概要
  • 主要企業
  • 競合状況・動向
    • 新製品の投入
    • M&A
    • 拡張
    • 合意

第10章 企業プロファイル

  • イントロダクション
  • AXOGEN, INC.
  • BAXTER INTERNATIONAL INC.
  • BOSTON SCIENTIFIC CORPORATION
  • CYBERONICS, INC.
  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • MEDTRONIC, PLC.
  • ST. JUDE MEDICAL, INC.
  • STRYKER CORPORATION
  • ORTHOMED S.A.S.
  • POLYGANICS B.V.
    • 財務情報
    • 製品・サービス
    • 戦略
    • 発展動向、など

第11章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3642

The global nerve repair and regeneration market is expected to reach USD 10,398.79 million by 2020 from USD 5,945.69 million in 2015 at a CAGR of 11.83%. Nerve injuries are most common in the upper (hand and arm) and lower (leg) extremities. Nerve damages can be caused by either blunt trauma, such as an impact from a fall or from traction injuries from motor vehicle accidents, or sharp trauma, such as direct cuts from a knife. Injury to a nerve can stop signals to and from the brain. Surgical nerve repair involves the exploration of the injured nerve and the removal of injured tissue from the nerve endings. Nerve repair and regeneration product are used through surgical interventions to restore normal function in nerves.

The rapidly increasing incidence of peripheral nerve injuries and neurological disorders is a major growth driver for this market. Furthermore, technological advancement in nerve repair and favorable reimbursement policies will aid the growth of this market.

This report segments the global nerve repair and regeneration market by product, application, and geography. The application segments included in this report are direct nerve repair/neurorrhaphy, nerve grafting, stem cell therapy, and neurostimulation and neuromodulation surgery. The direct nerve repair/neurorrhaphy segment is further categorized into epineural repair, perineural repair, and group fascicular repair. The nerve grafting surgeries segment is further categorized into autografts, allografts, and xenografts. The neurostimulation and neuromodulation segment is further categorized into external and internal neurostimulation and neuromodulation surgeries.

The product segments included in this report are biomaterials and neurostimulation and neuromodulation devices. The subsegments of the biomaterials segment are nerve conduits, nerve protectors, nerve wraps, and nerve connectors. The neurostimulation and neuromodulation devices segment is further categorized into internal and external neurostimulation and neuromodulation devices. The subsegments of the internal neurostimulation and neuromodulation product segment are spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electrical stimulation. The subsegments of the external neurostimulation and neuromodulation products segment are transcutaneous electrical nerve stimulation and transcranial magnetic stimulation.

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). North America is expected to account for the largest share of the global nerve repair and regeneration market in 2015. A number of factors, such as the high prevalence of chronic disorders like epilepsy, Parkinson's, Alzheimer's, chronic pain, urine and fecal incontinence, and depression, along with rise in aging population, will drive the neuromodulation market in North America. Furthermore, according to the Centers for Disease Control and Prevention, about 80% of people aged 65 and above suffer from at least one chronic condition. All these factors are expected to provide an impetus to the growth of the North American nerve repair and regeneration market. However, the high cost of neuromodulation devices and the presence of alternate therapies will restrain market growth.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global nerve repair and regeneration market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their nerve repair and regeneration market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all subsegments. It maps the market sizes and growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the nerve repair and regeneration market that covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and make strategic growth decisions.

The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of the top players in the nerve repair and regeneration market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the market
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the nerve repair and regeneration market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various nerve repair and regeneration products across geographies
  • Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the nerve repair and regeneration market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL NERVE REPAIR AND REGENERATION MARKET OVERVIEW
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCT
    • 5.2.2. BY APPLICATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Large numbers of nerve injuries and increasing incidences of neurological disorders
      • 5.3.1.2. Rapidly aging population worldwide
      • 5.3.1.3. Technological advancements in nerve repair to aid market growth
      • 5.3.1.4. Favorable reimbursement policies
      • 5.3.1.5. Expanded target applications and new indications are expected to increase the demand for neuromodulation devices.
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Lack of patient awareness
      • 5.3.2.2. Dearth of professionals, including trained surgeons
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Novel therapies such as stem cell therapy
      • 5.3.3.2. Emerging markets
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Donor site morbidity
      • 5.3.4.2. Inadequate nerve regeneration by conduits
      • 5.3.4.3. Stringent regulatory frameworks and time-consuming approval processes

6. NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. NEUROSTIMULATION AND NEUROMODULATION DEVICES
    • 6.2.1. INTERNAL NEUROSTIMULATION DEVICES
      • 6.2.1.1. Spinal cord stimulation
      • 6.2.1.2. Deep brain stimulation
      • 6.2.1.3. Vagus nerve stimulation
      • 6.2.1.4. Sacral nerve stimulation
      • 6.2.1.5. Gastric electrical stimulation
    • 6.2.2. EXTERNAL NEUROSTIMULATION DEVICES
      • 6.2.2.1. Transcutaneous electrical nerve stimulation
      • 6.2.2.2. Transcranial magnetic stimulation
  • 6.3. BIOMATERIALS
    • 6.3.1. NERVE CONDUITS
    • 6.3.2. NERVE PROTECTORS
    • 6.3.3. NERVE WRAPS
    • 6.3.4. NERVE CONNECTORS

7. NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. NEUROSTIMULATION AND NEUROMODULATION SURGERIES
    • 7.2.1. INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES
    • 7.2.2. EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES
  • 7.3. DIRECT NERVE REPAIR/NEURORRHAPHY
    • 7.3.1. EPINEURAL REPAIR
    • 7.3.2. PERINEURAL REPAIR
    • 7.3.3. GROUP FASCICULAR REPAIR
  • 7.4. NERVE GRAFTING
    • 7.4.1. AUTOGRAFT
    • 7.4.2. ALLOGRAFT
    • 7.4.3. XENOGRAFT
  • 7.5. STEM CELL THERAPY

8. NERVE REPAIR AND REGENERATION MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
  • 8.3. EUROPE
  • 8.4. ASIA
  • 8.5. REST OF THE WORLD

9. COMPETITIVE LANDSCAPE

  • 9.1. INTRODUCTION
  • 9.2. STRATEGIC OVERVIEW
  • 9.3. LEADING PLAYERS IN THE NERVE REPAIR AND REGENERATION MARKET
  • 9.4. COMPETITIVE SITUATION AND TRENDS
    • 9.4.1. NEW PRODUCT LAUNCHES
    • 9.4.2. ACQUISITIONS AND MERGERS
    • 9.4.3. EXPANSION
    • 9.4.4. AGREEMENTS

10. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 10.1. INTRODUCTION
  • 10.2. AXOGEN, INC.
  • 10.3. BAXTER INTERNATIONAL INC.
  • 10.4. BOSTON SCIENTIFIC CORPORATION
  • 10.5. CYBERONICS, INC.
  • 10.6. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • 10.7. MEDTRONIC, PLC.
  • 10.8. ST. JUDE MEDICAL, INC.
  • 10.9. STRYKER CORPORATION
  • 10.10. ORTHOMED S.A.S.
  • 10.11. POLYGANICS B.V.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. INSIGHTS OF INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. OTHER DEVELOPMENTS (JANUARY 2012-JUNE 2015)
  • 11.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.5. AVAILABLE CUSTOMIZATIONS
  • 11.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: NERVE REPAIR AND REGENERATION MARKET SUMMARY
  • TABLE 2: INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES AND NEUROLOGICAL DISORDERS ARE PROPELLING THE GROWTH OF THE NERVE REPAIR AND REGENERATION MARKET
  • TABLE 3: LACK OF TRAINED PROFESSIONALS TO NEGATIVELY IMPACT THE GROWTH OF THE NERVE REPAIR AND REGENERATION MARKET
  • TABLE 4: INCREASING USE OF STEM CELL THERAPY IS PAVING NEW GROWTH AVENUES FOR PLAYERS IN THE NERVE REPAIR AND REGENERATION MARKET
  • TABLE 5: STRINGENT REGULATORY FRAMEWORKS ARE A MAJOR CHALLENGE FOR PLAYERS IN THE NERVE REPAIR AND REGENERATION MARKET
  • TABLE 6: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 7: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 8: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: INTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 10: INTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: DEEP BRAIN STIMULATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: VAGUS NERVE STIMULATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: SACRAL NERVE STIMULATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: GASTRIC ELECTRICAL STIMULATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: EXTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 17: EXTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: TRANSCRANIAL MAGNETIC STIMULATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 21: BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: NERVE CONDUITS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: NERVE PROTECTOR MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: NERVE WRAPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: NERVE CONNECTOR MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 27: NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 28: NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: DIRECT NERVE REPAIR/NEURORRHAPHY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 32: DIRECT NERVE REPAIR/NEURORRHAPHY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: EPINEURAL REPAIR MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: PERINEURAL REPAIR MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: GROUP FASCICULAR REPAIR MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: NERVE GRAFTING MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 37: NERVE GRAFTING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: AUTOGRAFT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: ALLOGRAFT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: XENOGRAFT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: STEM CELL THERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 42: NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 44: NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 45: NORTH AMERICA: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 46: NORTH AMERICA: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 47: NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 48: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 49: EUROPE: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 50: EUROPE: NEUROSTIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 51: EUROPE: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 52: EUROPE: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 53: EUROPE: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 54: EUROPE: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 55: ASIA: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 56: ASIA: NEUROSTIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 57: ASIA: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 58: ASIA: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 59: ASIA: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 61: ROW: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 62: ROW: NEUROSTIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 63: ROW: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 64: ROW: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 65: ROW: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 66: ROW: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 67: MARKET DEVELOPMENTS BETWEEN 2012 AND 2015
  • TABLE 68: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 69: ACQUISITIONS AND MERGERS, 2012-2015
  • TABLE 70: EXPANSIONS, 2012-2015
  • TABLE 71: AGREEMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL NERVE REPAIR AND REGENERATION MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015 VS. 2020
  • FIGURE 8: BIOMATERIALS MARKET, BY PRODUCT, 2015 VS. 2020
  • FIGURE 9: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY PRODUCT, 2015 VS. 2020
  • FIGURE 10: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY PRODUCT, 2015 VS. 2020
  • FIGURE 11: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY PRODUCT, 2015 VS. 2020
  • FIGURE 12: NERVE REPAIR AND REGENERATION MARKET, BY REGION, 2015 VS. 2020
  • FIGURE 13: INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES & NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH
  • FIGURE 14: NEUROSTIMULATION & NEUROMODULATION SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015
  • FIGURE 15: ASIA TO WITNESS FASTEST GROWTH RATE IN THE FORECAST PERIOD (2015 TO 2020)
  • FIGURE 16: ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 17: NERVE REPAIR AND REGENERATION MARKET SEGMENTATION: BY PRODUCT
  • FIGURE 18: NERVE REPAIR AND REGENERATION MARKET SEGMENTATION: BY APPLICATION
  • FIGURE 19: INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES AND NEUROLOGICAL DISORDERS WILL DRIVE THE NERVE REPAIR AND REGENERATION MARKET IN THE FORECAST PERIOD
  • FIGURE 20: GROWING AGING POPULATION IS AN IMPORTANT DRIVER FOR THE NERVE REPAIR AND REGENERATION MARKET
  • FIGURE 21: GROWTH IN HEALTHCARE EXPENDITURE IN ASIA AND ROW OUTPACING THAT OF NORTH AMERICA AND EUROPE
  • FIGURE 22: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
  • FIGURE 23: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT, 2015 (USD MILLION)
  • FIGURE 24: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES TO DOMINATE MARKET IN 2015
  • FIGURE 25: NORTH AMERICA EXPECTED TO HOLD LARGEST SHARE OF THE NEUROSTIMULATION AND NEUROMODULATION DEVICES SEGMENT
  • FIGURE 26: NERVE CONDUITS ACCOUNT FOR THE LARGEST SHARE OF THE BIOMATERIALS SEGMENT IN 2015
  • FIGURE 27: NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE BIOMATERIALS MARKET DURING THE FORECAST PERIOD
  • FIGURE 28: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION
  • FIGURE 29: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION, 2015 (USD MILLION)
  • FIGURE 30: INTERNAL SURGERIES ACCOUNT FOR THE LARGEST SHARE OF THE NEUROSTIMULATION AND NEUROMODULATION APPLICATION SEGMENT
  • FIGURE 31: NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE NEUROSTIMULATION AND NEUROMODULATION SURGERIES SEGMENT IN 2015
  • FIGURE 32: EPINEURAL REPAIR ACCOUNTS FOR THE LARGEST SHARE OF THE DIRECT NERVE REPAIR/NEURORRHAPHY SEGMENT IN 2015
  • FIGURE 33: NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE DIRECT NERVE REPAIR/NEURORRHAPHY SEGMENT IN 2015
  • FIGURE 34: AUTOGRAFTS ACCOUNT FOR THE LARGEST SHARE OF THE NERVE GRAFTING SEGMENT IN 2015
  • FIGURE 35: NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE NERVE GRAFTING SEGMENT IN 2015
  • FIGURE 36: NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE STEM CELL THERAPY SEGMENT IN 2015
  • FIGURE 37: NERVE REPAIR AND REGENERATION MARKET SEGMENTATION, BY REGION
  • FIGURE 38: NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION (MARKET SIZE AND GROWTH RATE)
  • FIGURE 39: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT
  • FIGURE 40: NEUROSTIMULATION AND NEUROMODULATION DEVICES TO DOMINATE THE NERVE REPAIR AND REGENERATION MARKET IN NORTH AMERICA
  • FIGURE 41: INTERNAL NEUROSTIMULATION TO FORM THE LARGEST SEGMENT OF THE MARKET IN NORTH AMERICA IN 2015
  • FIGURE 42: NERVE CONDUITS TO FORM THE LARGEST SEGMENT OF THE BIOMATERIALS MARKET IN NORTH AMERICA
  • FIGURE 43: NEUROSTIMULATION AND NEUROMODULATION SURGERY TO BE THE LARGEST APPLICATION SEGMENT OF THE MARKET IN NORTH AMERICA (2015)
  • FIGURE 44: NEUROSTIMULATION AND NEUROMODULATION DEVICES DOMINATED THE MARKET IN EUROPE (2015)
  • FIGURE 45: INTERNAL NEUROSTIMULATION TO FORM THE LARGEST SEGMENT OF THE NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET IN EUROPE (2015)
  • FIGURE 46: NERVE CONDUITS TO FORM THE LARGEST SEGMENT OF THE BIOMATERIALS MARKET IN EUROPE (2015)
  • FIGURE 47: NEUROSTIMULATION AND NEUROMODULATION SURGERY ESTIMATED TO BE THE LARGEST APPLICATION SEGMENT OF THE MARKET IN EUROPE
  • FIGURE 48: ASIA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT
  • FIGURE 49: NEUROSTIMULATION AND NEUROMODULATION DEVICES TO DOMINATE THE MARKET IN ASIA (2015)
  • FIGURE 50: INTERNAL NEUROSTIMULATION TO FORM THE LARGEST SEGMENT OF THE NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET IN ASIA
  • FIGURE 51: NERVE CONDUITS TO COMMAND THE LARGEST SHARE OF THE BIOMATERIALS MARKET IN ASIA
  • FIGURE 52: NEUROSTIMULATION AND NEUROMODULATION SURGERY TO BE THE LARGEST APPLICATION SEGMENT OF THE MARKET IN ASIA (2015)
  • FIGURE 53: NEUROSTIMULATION AND NEUROMODULATION DEVICES DOMINATED THE ROW MARKET IN 2015
  • FIGURE 54: INTERNAL NEUROSTIMULATION TO DOMINATE THE NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET IN THE ROW
  • FIGURE 55: NERVE CONDUITS ESTIMATED TO COMMAND THE LARGEST SHARE OF THE BIOMATERIALS MARKET IN THE ROW
  • FIGURE 56: NEUROSTIMULATION AND NEUROMODULATION SURGERY TO BE THE LARGEST APPLICATION SEGMENT OF THE ROW MARKET (2015)
  • FIGURE 57: KEY DEVELOPMENTS IN THE NERVE REPAIR AND REGENERATION MARKET, 2012-2015
  • FIGURE 58: NERVE REPAIR AND REGENERATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 59: SNAPSHOT OF FINANCIAL PERFORMANCE OF LEADING MARKET PLAYERS
  • FIGURE 60: AXOGEN, INC.: COMPANY SNAPSHOT
  • FIGURE 61: BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • FIGURE 62: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 63: CYBERONICS, INC.: COMPANY SNAPSHOT
  • FIGURE 64: INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 65: MEDTRONIC, PLC.: COMPANY SNAPSHOT
  • FIGURE 66: ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 67: STRYKER CORPORATION: COMPANY SNAPSHOT
Back to Top